Koyfin Home > Directory > Health Care > Aduro Biotech > Return on Equity %

Aduro Biotech Return on Equity % Chart (ADRO)

Aduro Biotech annual/quarterly Return on Equity % from 2014 to 2020.
  • Aduro Biotech Return on Equity % for the quarter ending June 06, 2020 was -125.16 a 26.86% decrease of -33.62 year over year
  • Aduro Biotech Return on Equity % for the last 12 months ending June 06, 2020 was -87.44 a 14.82% decrease of -12.96 year over year
  • Aduro Biotech Annual Return on Equity % for 2019 was -82.00 a 37.61% decrease of -30.84 from 2018
  • Aduro Biotech Annual Return on Equity % for 2018 was -51.16 a 22.72% decrease of -11.62 from 2017
  • Aduro Biotech Annual Return on Equity % for 2017 was -39.54 a 5.68% decrease of -2.25 from 2016
Other Margins & Efficiency Metrics:
  • Aduro Biotech EBITDA Margin for the quarter ending June 06, 2016 was $10m a 1,081.69% increase of 105m year over year
  • Aduro Biotech Return on Capital % for the quarter ending December 12, 2018 was -41.94 a 38.72% decrease of -16.24 year over year
View Chart On Koyfin

Quarterly ADRO Return on Equity % Data

06/2020-125.16
03/2020-48.41
12/2019-105.20
09/2019-91.55
06/2019-68.67
03/2019-74.76
12/2018-71.86
09/2018-55.42
06/2018-52.27
03/2018-39.58

Annual ADRO Return on Equity % Data

2019-82.00
2018-51.16
2017-39.54
2016-37.29
2015-23.04
2014-47.06
2013308.82